Zulkarnain Zulkarnain
Department of Physiology, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

SARS-CoV-2 infection and male fertility problems Ika Inda Bani; Zulkarnain Zulkarnain; Gholib Gholib; Dedy Syahrizal; Fauzul Husna; Winda Yulia; Mulkan Azhari
Trends in Infection and Global Health Vol 2, No 2 (2022): December 2022
Publisher : School of Medicine, Universitas Syiah Kuala

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24815/tigh.v2i2.29426

Abstract

In 2019, the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has killed more than 6.6 millions of people around the world as of end of 2022. The long-term impact of COVID-19 is persisted, including its impact on male reproduction. SARS-CoV-2 enters into host cells using the angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) receptors. Both of these receptors are expressed more in men, and therefore men are more susceptible to SARS-CoV-2. COVID-19 potentially cause infertility by damaging testicular tissues and interfering with the process of spermatogenesis. A decrease in serum levels of testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) as well as a decrease in sperm quality in men with COVID-19 compared to healthy men of the same age has been reported in several studies. Utilizing existing research data, this study aims to explore in detail of how SARS-CoV-2 tends to affect male fertility.
Beyond eGFR and proteinuria: Noninvasive ultrasonographic markers of renal impairment in diabetic kidney disease Rahmat A. Syahri; Nurhayani D. Susanti; Rima Novirianthy; Iskandar Zakaria; Zulkarnain Zulkarnain
Narra J Vol. 6 No. 3 (2026): December 2026 (In Press)
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v6i3.3146

Abstract

Current literature regarding the combined associations of structural renal ultrasonographic parameters and renal resistive index (RRI) with diabetic kidney disease (DKD) severity remains limited, particularly in Southeast Asian populations. The aim of this study was to explore the associations of renal ultrasonographic parameters with estimated glomerular filtration rate (eGFR) and proteinuria among patients with DKD. A cross-sectional study was conducted involving 51 patients with DKD. Bilateral renal longitudinal diameter, cortical thickness, parenchymal echogenicity, and RRI were assessed using ultrasonography. Renal function was evaluated using the 2021 Chronic Kidney Disease Epidemiology Collaboration creatinine-based eGFR equation, and proteinuria was categorized from urine dipstick results as absent-to-mild (negative, trace, or 1+) or moderate-to-severe (2+ to 4+). The present study found that higher eGFR correlated with greater right renal longitudinal diameter (r=0.347, p=0.013), but not with left renal diameter (r=0.253, p=0.073). Cortical thickness was not correlated with eGFR in either kidney. RRI was inversely correlated with eGFR bilaterally (r=−0.491 for both; p<0.001). Mean eGFR was numerically lower in patients with increased parenchymal echogenicity than in those with normal echogenicity, but the differences were not significant. Renal longitudinal diameter, cortical thickness, and parenchymal echogenicity did not differ significantly between proteinuria groups. The mean right RRI was lower in patients with moderate-to-severe proteinuria than in those with absent-to-mild proteinuria (0.66±0.11 vs 0.75±0.08, p=0.038), whereas left RRI did not differ significantly (p=0.231). In conclusion, bilateral RRI was consistently associated with lower eGFR, whereas associations involving structural ultrasonographic parameters and proteinuria were less consistent, suggesting that RRI may complement conventional assessment of kidney function in DKD; however, its clinical and prognostic value requires confirmation in larger prospective studies.